Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Miltefosine and intralesional pentamidine for L. braziliensis cutaneous leishmaniasis
NCT03445897Phase 2Completed
- Start
- Jan 2016
- Primary completion
- Jan 2018
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
01
Overview
A Phase 2 trial of miltefosine, pentamidine in cutaneous leishmaniasis (CL). Started Jan 2016; status: completed.
02
Drugs
miltefosinepentamidine
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on NCT03445897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03445897.